title: Septic shock after treatment of pyoderma gangrenosum with infliximab.
authors.forename: Florian
authors.initials: F
authors.lastname: Wölbing
authors.forename: Gerhard
authors.initials: G
authors.lastname: Fierlbeck
authors.forename: Wolfram
authors.initials: W
authors.lastname: Hötzenecker
authors.forename: Martin
authors.initials: M
authors.lastname: Schaller
authors.forename: Martin
authors.initials: M
authors.lastname: Röcken
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D012772:Shock, Septic / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab